Journal
BIOMARKERS IN MEDICINE
Volume 16, Issue 13, Pages 993-1004Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2022-0368
Keywords
asymmetric dimethylarginine; endothelial dysfunction; gout disease; hyperuricemia; nitric oxide
Categories
Ask authors/readers for more resources
This study found that serum levels of methylarginine derivatives and related metabolites were higher in patients with gout compared to the control group, while serum levels of arginine and homoarginine were lower. There may be an association between gout, methylarginine levels, hyperuricemia, and increased risk of cardiovascular disease.
Aim: The aim of this study was to measure serum levels of methylarginine derivatives and related metabolites in patients with gout. Materials & methods: This study enrolled 100 patients with gout and 80 patients in the control group. Serum asymmetric dimethylarginine, symmetric dimethylarginine, L-N-monomethylarginine, arginine, homoarginine, citrulline and ornithine levels were measured with tandem mass spectrometry. Results: Serum ornithine, citrulline and total methylated arginine load levels were statistically significantly higher in patients with gout compared with the control group, while serum arginine and homoarginine levels and global arginine bioavailability ratio were statistically significantly lower. Conclusion: There may be an association between gout, methylarginine levels and hyperuricemia and increased risk of cardiovascular disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available